structural heart disease Valvular heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Subjects who will be undergoing a cardiac intervention where routinely TEE or ICE imaging is used • Subjects who will be subject to a procedure where atrial transseptal puncture is required • Subjects who will undergo a LAA (left atrial appendage) closure procedure • Subjects who will undergo a PFO (patent fossa ovalis) closure procedure • Subject who are 18 years of age or older • Subject who will give informed consent to participate in the study
Exclusion criteria
Exclusion criteria: • Subject is younger that 18 years of age • Subjects who will not give informed consent to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective of this clinical study is: • to establish that microTEE can view the same required anatomical features as TEE and ICE for their respective purposes. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary objectives are: • to establish that microTEE can be used without the use of general anesthesia • to establish that transnasal use of a S8-3t microTEE probe is feasible • to collect anonymised X-ray fluoroscopy and microTEE data for prototype development of fused X-ray and echography imaging | — |
Countries
Netherlands